Related Experiment Video
Updated: May 29, 2026

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α
Published on: November 2, 2018
The E3 ubiquitin ligase mind bomb-2 (MIB2) protein controls B-cell CLL/lymphoma 10 (BCL10)-dependent NF-κB activation
Cinthia C Stempin1, Liying Chi, Juan P Giraldo-Vela
1Department of Infectious Diseases, St. Jude Children’s Research Hospital, Memphis, Tennessee 38105, USA.
Insights
The E3 ligase MIB2 is a newly discovered component of the BCL10 signaling complex. MIB2 is essential for BCL10-mediated activation of NF-κB by regulating key downstream signaling molecules.
Area of Science:
- Immunology
- Molecular Biology
- Cell Signaling
Background:
- B-cell CLL/lymphoma 10 (BCL10) is vital for NF-κB activation in immune receptor signaling.
- The precise mechanisms linking BCL10 to downstream kinases like TAK1 and IKK remain unclear.
Purpose of the Study:
- To identify novel components of the activated BCL10 complex.
- To elucidate the role of these components in NF-κB signaling.
Main Methods:
- Proteomic analysis to identify interacting proteins.
- In vitro translation and pulldown assays to confirm interactions.
- Overexpression and knockdown experiments to assess functional roles.
Main Results:
- The E3 ligase MIB2 was identified as a novel component of the activated BCL10 complex.
- Direct interaction between BCL10 and MIB2 was confirmed.
- MIB2 promotes BCL10-mediated NF-κB activation by facilitating autoubiquitination of IKKγ/NEMO and TAK1 recruitment/activation.
- MIB2 knockdown inhibited BCL10-dependent NF-κB activation.
Conclusions:
- MIB2 is a novel, essential component of the activated BCL10 signaling complex.
- MIB2 acts as a missing link in the BCL10-dependent NF-κB signaling pathway, regulating downstream kinase activation.
Abstract:
B-cell CLL/lymphoma 10 (BCL10) is crucial for the activation of NF-κB in numerous immune receptor signaling pathways, including the T-cell receptor (TCR) and B-cell receptor signaling pathways. However, the molecular mechanisms that lead to signal transduction from BCL10 to downstream NF-κB effector kinases, such as TAK1 and components of the IKK complex, are not entirely understood. Here we used a proteomic approach and identified the E3 ligase MIB2 as a novel component of the activated BCL10 complex. In vitro translation and pulldown assays suggest direct interaction between BCL10 and MIB2. Overexpression experiments show that MIB2 controls BCL10-mediated activation of NF-κB by promoting autoubiquitination and ubiquitination of IKKγ/NEMO, as well as recruitment and activation of TAK1. Knockdown of MIB2 inhibited BCL10-dependent NF-κB activation. Together, our results identify MIB2 as a novel component of the activated BCL10 signaling complex and a missing link in the BCL10-dependent NF-κB signaling pathway.
More Related Videos
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Abnormal Proliferation
Master Transcription Regulators
The Intrinsic Apoptotic Pathway
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...

